GC
HPTX

Guggenheim Capital’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Guggenheim Capital’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,851
Closed -$406K – 3171
2015
Q1 		$406K Buy
8,851
+27
+0.3% +$808 ﹤0.01% 2607
2014
Q4 		$212K Buy
+8,824
New +$199K ﹤0.01% 2781

Guggenheim Capital's HPTX Position: Q2 2015 in Review

Guggenheim Capital sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 8,851 shares — an estimated $406K sold.

Guggenheim Capital first reported a position in HPTX in Q4 2014 and held it in 2 quarters. The position peaked at $406K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Guggenheim Capital reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Guggenheim Capital sold 8,851 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $406K.
  • Guggenheim Capital first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • Guggenheim Capital's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $406K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Guggenheim Capital's 13F filing for Q2 2015, filed 14 Aug 2015.